Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Stroke. 2012 Feb 2;43(4):958–966. doi: 10.1161/STROKEAHA.111.641324

Table 3.

Baseline lipid biomarkers in the study population

# Case-Control Pairs Control Subjects Cases P value
Total cholesterol 770 230.0 (204.0, 254.0) 230.0 (207.0, 254.0) 0.15
Total cholesterol/HDL 769 3.9 (3.1, 4.9) 4.1 (3.3, 5.1) <0.001
Triglycerides 770 140.0 (102.0, 189.0) 155.5 (112.0, 217.0) <0.001
HDL cholesterol 769 58.0 (48.0, 71.0) 56.0 (46.0, 67.0) <0.001
HDL particle number 729 31.7 (27.6, 36.3) 31.8 (27.3, 35.6) 0.15
HDL size 729 9.0 (8.6, 9.4) 9.0 (8.6, 9.3) <0.01
IDL particle number 729 58.0 (28.0, 96.0) 67.0 (35.0, 106.0) <0.01
LDL cholesterol 748 137.8 (113.9, 164.7) 138.6 (116.7, 162.2) 0.47
LDL particle number 729 1442.0 (1222.0, 1713.0) 1511.0 (1283.0, 1798.0) <0.01
LDL size 729 21.3 (20.8, 21.7) 21.2 (20.7, 21.7) 0.03
VLDL triglyceride 729 78.0 (50.0, 119.0) 91.0 (56.0, 137.0) <0.001
VLDL particle number 729 80.0 (57.0, 105.8) 85.3 (60.9, 114.9) <0.01
VLDL size 729 44.8 (40.4, 50.5) 46.4 (41.8, 52.3) <0.001
Lipoprotein (a) 739 10.0 (5.0, 26.0) 10.0 (5.0, 31.0) 0.11

Values are given as median (interquartile range)